Chen Liequan is the largest shareholder and chairman of Guanfu Holding Co., Ltd., and also the chairman of Nengte Technology Co., Ltd., under the leadership of Chen Liequan, the US-China Nengte Pharmaceutical and Chemical Technology Co., Ltd., which was on the verge of bankruptcy, turned losses into profits that year, and became the largest MK5 intermediate supplier in China the following year, with a rapid increase in output value and profit. On March 14, 2022, the total market value of Guanfu reached 91.6000 .1000.000000000005